Efficacy of probiotic treatment as post-exposure prophylaxis for COVID-19: A double-blind, Placebo-Controlled Randomized trial

• DOI: 10.1016/j.clnu.2023.11.043
• Publication Date: 2023-12-11T20:18:36Z
• Authors: Paul E. Wischmeyer; Helen Tang; Yi Ren; Lauren Bohannon; Danting Jiang; Matthew Bergens; Zeni E. Ramirez; Tessa M. Andermann; Julia A. Messina; Julia A. Sung; David Jensen; Sin-Ho Jung; Alexandra Artica; Anne Britt; Amy Bush; Ernaya Johnson; Meagan V. Lew; Hilary Winthrop; Claudia Pamanes; Alessandro Racioppi; Aaron T. Zhao; Zihan Wan; Neeraj K. Surana; Anthony D. Sung
• Keywords: Common cold

The COVID-19 pandemic continues to pose unprecedented challenges worldwide health. While vaccines are effective, additional strategies mitigate the spread/severity of continue be needed. Emerging evidence suggests susceptibility respiratory tract infections in healthy subjects can reduced by probiotic interventions; thus, probiotics may a low-risk, low-cost, and easily implementable modality reduce risk COVID-19.